• Innovent Announces First Patient Dosed in Anti-CD47 Trial americanpharmaceuticalreview
    January 16, 2019
    Innovent Biologics announced the first patient has been successfully dosed in a phase I clinical trial of anti-CD47 monoclonal antibody (IBI188) for patients with advanced malignancies....
PharmaSources Customer Service